<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04139447</url>
  </required_header>
  <id_info>
    <org_study_id>2013_11</org_study_id>
    <secondary_id>2013-A01632-43</secondary_id>
    <nct_id>NCT04139447</nct_id>
  </id_info>
  <brief_title>DAnalysis of the Distribution of Adrenal Steroids in a Control Population</brief_title>
  <acronym>STEROTEM</acronym>
  <official_title>Analysis of the Distribution of Adrenal Steroids in Blood and Urine Measured by Mass Spectrometry Coupled to Liquid Chromatography in a Control Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AREM (Association Régionale Endocrinologie Métabolisme)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a biomedical research study on the determination of adrenal steroids. It has been
      proposed in recent years as a tool for the diagnostic orientation of an adrenal pathology.
      The main objective is to analyze the distribution of blood and urinary adrenal steroid values
      in a population of 60 controls. The secondary objective is to establish reference values for
      each of these parameters, if their distribution permits, and to study the possible link
      between the blood pressure level, the orthostatism state, the potassium level and these
      adrenal steroids.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Actual">September 2018</completion_date>
  <primary_completion_date type="Actual">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>difference of the distribution of blood steroid values in a population control group</measure>
    <time_frame>At baseline</time_frame>
    <description>The value will be measured by mass spectrometry coupled with liquid chromatography (HPLC-MS) and 16 global parameters will be analyses (B, 18-OH B, DOC, 18-OH DOC, S, F, 18-OH F, 17-OH progesterone, 21-desoxycortisol, delta 4 androstenedione, 17OHpregnenolone, aldosterone, SDHA, E, testosterone, estradiol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>difference of the distribution of urinary steroid values in a population control group</measure>
    <time_frame>At baseline</time_frame>
    <description>The value will be measured by mass spectrometry coupled with liquid chromatography (HPLC-MS) and 6 global parameters will be analyses (E, F, THF, aTHF, THE, aldosterone)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure taken while sitting, lying or standing</measure>
    <time_frame>At baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood concentration of kaliemia</measure>
    <time_frame>at baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Adrenal Disease</condition>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum, urine.

        -  blood ionogram, serum creatinine, CO2T (heparin tube)

        -  Plasma Renin Activity 5PRA)

        -  Steroid blood (B, 18-OH B, DOC, 18-OH DOC, S, F, 18-OH F, 17-OH progesterone,
           21-deoxycortisol, delta 4 androstenedione, 17-OH pregnenolone, aldosterone, SDHA)

        -  Urine ionogram (natriuresis, kaliuresis)

        -  Steroid Urine (E, F, THF, aTHF, THE, aldosterone)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Biomedical research to analyze the distribution of blood and urinary adrenal steroid values
        in a population of 60 healthy controls.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Negative blood pregnancy test

          -  Normosalt diet

          -  Men and women ≥ 18 years

          -  Being able and willing to give written informed consent

        Exclusion Criteria:

          -  Personal history of diabetes, high blood pressure, adrenal pathologies.

          -  Family history of adrenal pathologies.

          -  Taking of the following drugs:

        Antihypertensives drugs: ACE inhibitor, Angiotensin II receptor, beta-blocker, thiazide
        diuretic, loop diuretic, anti-aldosterone, dihydropyridine-type calcium antagonist.

          -  Hormone replacement therapy, cyproterone acetate

          -  NSAID (except occasional intake), corticosteroid

          -  Antidepressant: serotonin reuptake inhibitor (paroxetine, fluoxetine, sertraline,
             citalopram)

          -  Contraception or estrogen / progestin treatment (progestins only allowed)

          -  Not be able to keep standing position.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Douillard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU, Hôpital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>January 14, 2019</study_first_submitted>
  <study_first_submitted_qc>October 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2019</study_first_posted>
  <last_update_submitted>October 24, 2019</last_update_submitted>
  <last_update_submitted_qc>October 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adrenal steroids</keyword>
  <keyword>mass spectroscopy</keyword>
  <keyword>liquid chromatography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenal Gland Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

